In our previous report, we showed the increased frequency of circulating CTLA-4+ T cell subtypes as well as the disturbed kinetics of its expression, suggesting a suppressed T cell-mediated immunity in CLL [2]. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.